Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

Kymera Therapeutics, Inc. (KYMR) Insider Trading

2 open-market trades reported since Sep 4, 2026: 0 purchases worth $0 and 2 sales worth $4.16M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Nello MainolfiCEO0$01$3.41MOct 1, 2026
Brian AdamsGeneral Counsel0$01$744KSep 4, 2026

All trades

KYMR insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 1Oct 1Nello MainolfiCEOCEO▼ SELL10b5-130,000113.80$3.41M−4.3%Form 4 ↗
Sep 4Sep 4Brian AdamsGeneral CounselGeneral Counsel▼ SELL6,371116.83$744K−11%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings